Dr. Lalit Kumar

Dr. Lalit Kumar performs major interventions in the following specialities:

• Interventional Cardiology

• MBBS
• MD Internal Medicine
• DM Interventional Cardiology

• Gupta VK, Pannu D, Singh MP, Kumar L. Effect of SGLT-2 inhibitor (remogliflozin) plus DPP4 inhibitor (vildagliptin) on diabetic nephropathy in patients with type 2 diabetes mellitus comparison with combination of metformin and sulphonylureas. Int J Adv Med. 2023;10(6):446-451.
• Singh PB, Verma RK, Giri R, et al. Efficacy and Safety of Methotrexate Plus Leflunomide in Patients of Rheumatoid Arthritis not Responding to Methotrexate Alone. J Clin Res Applied Med. 2023;3(1):05-08.
• Giri R, Yadav PK, Agarwal S, Kumar L. Assessment of prognostic value of FT3, FT4 and TSH among critically ill patients. Int J Adv Med. 2021;8(6):775.
• Giri R, Ahamed F, Agarwal S, Kumar L. Assessment of serum ferritin and thyroid hormones level in acute ischemic stroke and their association with hemorrhagic conversion. Int J Adv Med. 2021;8(5):672.
• Singh N, Kumar L, Singh DN, Kumar V. Frequency of opportunistic infection in PL HIV and its role in monitoring of ART 1 failure. Int J Adv Med. 2020;7(7):1165.
• Verma RK, Singh N, Giri R, Kumar L, Singh DN, Kumar V. Comparision and evaluation of the clinical features of the patients of ART 1 failure who have started ART 2 medication. Int J Adv Med. 2020;7(7):1112.
• Singh N, Kumar L, Singh DN. Evaluation of adverse effect of second line ART in PL HIV patients treated by second line ART. Int J Adv Med. 2020;7(6):916.

• Consultant - SSB Heart And Multispecialty Hospital, Sector 20 A